Spyre Therapeutics Inc
(NAS:SYRE)
$
87.38
+0.29 (+0.34%)
Market Cap: 7.70 Bil
Enterprise Value: 6.71 Bil
PE Ratio: 0
PB Ratio: 8.06
GF Score: 26/100 Spyre Therapeutics Inc (SYRE) Transcripts
- 1